Instrumento Inactivo

Acciones Vitae Pharmaceuticals Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17/10/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15/09/16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14/09/16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14/09/16

Directores	Puesto	Edad	Desde
Ambrose Bailey PSD	President	60	25/10/16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06/06/16
John Grosso BRD	Director/Board Member	-	-

Administradores	Puesto	Edad	Desde
John Grosso BRD	Director/Board Member	-	-

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-4,66 %	86,13 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+1,32 %	39,82 mil M
BIOGEN INC.	-19,27 %	30,42 mil M
UCB	+57,86 %	25,23 mil M
BIOMARIN PHARMACEUTICAL INC.	-16,09 %	15,36 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14 %	11,95 mil M
INCYTE CORPORATION	-17,69 %	11,6 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00 %	11,51 mil M
SWEDISH ORPHAN BIOVITRUM AB	+5,24 %	8710,47 M